P. B. Deshpande

Former Chief Scientific Officer at Parabolic Drugs Ltd.

P. B. Deshpande

P. B. Deshpande

Former Chief Scientific Officer at Parabolic Drugs Ltd.

Biography

Dr. P. B. Deshpande is Chief Scientific Officer at Parabolic Drugs Ltd.Dr. Deshpande was previously employed as Senior Vice President by Alembic Ltd. He also served on the board at Marksans Pharma Ltd.

Overview
RelSci Relationships

49

Birthday

1955

Age

63

Relationships
RelSci Relationships are individuals P. B. Deshpande likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Operating Officer & Non-Independent Executive Director at Marksans Pharma Ltd.

Relationship likelihood: Average

Co-Founder at Parabolic Drugs Ltd.

Relationship likelihood: Average

Founder at Parabolic Drugs Ltd.

Relationship likelihood: Average

Former Vice President-Research & Development at Parabolic Drugs Ltd.

Relationship likelihood: Average

Senior Vice President-Finance & Accounts at Parabolic Drugs Ltd.

Relationship likelihood: Average

Senior Vice President-Human Resources & Administration at Parabolic Drugs Ltd.

Relationship likelihood: Average

Former Chief Financial Officer & Head-Investor Relations at Parabolic Drugs Ltd.

Relationship likelihood: Average

Former President-Operations at Parabolic Drugs Ltd.

Relationship likelihood: Average

Secretary & Chief Compliance Officer at Schaeffler India Ltd.

Relationship likelihood: Average

General Manager, Corporate Quality at Parabolic Drugs Ltd.

Relationship likelihood: Average

Paths to P. B. Deshpande
Potential Connections via
Relationship Science
You
P. B. Deshpande
Former Chief Scientific Officer at Parabolic Drugs Ltd.
Career History
Chief Scientific Officer
2010 - 2011

Parabolic Drugs Ltd. develops and manufactures active pharmaceutical ingredients and intermediates. Its product portfolio includes oral and sterile semi synthetic penicillin active pharmaceutical ingredients, oral and sterile cephalosporin API in antibiotic segment to non-antibiotic API in the cardiovascular, NSAID, anti-hypertensive and osteoporosis segments. The company was founded by Pranav Gupta and Vineet Gupta on February 22, 1996 and is headquartered in Chandigarh, India.

Director-Active Pharmaceutical Ingredients
2007 - 2008

Marksans Pharma Ltd. engages in the business of manufacture and marketing of pharmaceutical formulations. Its product portfolio spreads over major therapeutic areas such as oncology, gastroenterology, anti-diabetic, cardiovascular, pain management and gynecology. The company was founded by Mark Saldanha on April 16, 1992 and is headquartered in Mumbai, India.

Senior Vice President
Prior

Alembic Ltd. is a pharmaceutical holding company. It operates through the Active Pharmaceutical Ingredient (API) and Real Estate business segments. The API segment manufactures and markets fermentation and chemistry based API. The Real Estate segment comprises of the construction of residential and commercial real estate projects; and project management and marketing consultancy. The company was founded on July 30, 1907 and is headquartered in Vadodara, India.

Other Affiliations

P. B. Deshpande is affiliated with Parabolic Drugs Ltd., Marksans Pharma Ltd., Alembic Ltd.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by P. B. Deshpande. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of P. B. Deshpande's profile does not indicate a business or promotional relationship of any kind between RelSci and P. B. Deshpande.